Alcohol Abuse Clinical Trial
Official title:
The Effects of Electronic Cigarette Use on Alcohol Consumption: A Neurocognitive and Behavioral Investigation
Verified date | November 2018 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to 1) examine cognitive acuity following e-cig use (as compared to no e-cig use), 2) examine motor coordination following beer and e-cig use (as compared to beer consumption only).
Status | Completed |
Enrollment | 35 |
Est. completion date | November 11, 2018 |
Est. primary completion date | November 11, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Healthy men and women, 21 years of age or older - Regular alcohol use (reports at least one drink weekly - acceptability of average alcohol consumption will be made on a case by case basis by the PI) - No current/prior severe alcohol or substance use disorder (endorsement of > 6 Alcohol/Drug Use history items on the phone screen) - Current e-cigarette use (reports at least weekly use - acceptability of average e-cig use will be made on a case by case basis by the PI) - Able to understand questionnaires/procedures in English - Reports drinking beer (Yes/No on phone screen) Exclusion Criteria: - Pregnant/breast-feeding women (assessed via phone screen and urine screen) - Unstable or significant medical disorders that may influence study outcome or participant safety as determined by Melissa Cyders (e.g., liver condition) - Current/prior severe alcohol use disorder, current/prior severe substance use disorder (endorsement of > 6 Alcohol/Drug Use history items on the phone screen) - Positive urine drug screen for amphetamines/meth-amphetamines, barbiturates, benzodiazapines, cocaine, opiates, or PCP [1-phenylcyclohexyl] - Current mental health problems, such as depression, anxiety, post-traumatic stress disorder, bipolar disorder, or schizophrenia (self-reported at phone screen) - Positive BrAC reading at the start of any study visit - Court-mandated order to not drink alcohol - Any condition that, in the judgment of the PI, could place the participant at risk or affect data validity |
Country | Name | City | State |
---|---|---|---|
United States | Indiana Univerisity Purdue University Indianapolis | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Alcohol related attentional bias-Reaction time | -Subtracting average time to respond to alcohol stimuli from the average time to respond to non-alcohol stimuli -Faster reaction times to probes that replace alcohol-related versus control pictures are indicative of alcohol-related attentional biases | Through 15 minute eye-tracking session | |
Primary | Alcohol related attentional bias-Initial orientation | -Percentage calculated based on the number of trials when gaze was initially directed at the alcohol-related picture and the total number of trials in which a fixation was made on either the alcohol-related or control picture | Through 15 minute eye-tracking session | |
Primary | Alcohol related attentional bias-Delayed disengagement | Summing the total amount of time that fixations were directed at the regions of the screen occupied by the alcohol pictures and control pictures, respectively | Through 15 minute eye-tracking session | |
Primary | Amount of beer consumed | mL of beer consumed | 60 minutes ad libitum alcohol session | |
Primary | E-cigarette puffs | Number of times participant takes a hit (inhales and exhales vapor) from their e-cig. | 60 minutes ad libitum alcohol session | |
Primary | Alcohol sips | Number of times participant takes a drink of a beer | 60 minute ad libitum alcohol session | |
Secondary | Alcohol craving | 0 (not at all) to 10 (very much) | Immediately prior to first e-cig prime, immediately following first e-cig prime , immediately prior to second e-cig prime, immediately following second e-cig prime, immediately following 60 minute ad lib session | |
Secondary | E-cig craving | 0 (not at all) to 10 (very much) | Immediately prior to first e-cig prime, immediately following first e-cig prime , immediately prior to second e-cig prime, immediately following second e-cig prime, immediately following 60 minute ad lib session | |
Secondary | Timeline Followback combined e-cig and alcohol use | Number of days that participant reports using their e-cig during a period of alcohol consumption | 30 days prior to study session | |
Secondary | Amount of e-cig used | The weight (grams) of the e-cig prior to the ad libitum alcohol session minus the weight (grams) of the e-cig following the ad libitum alcohol session | Pre and post 60 minute ad libitum alcohol session |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03165942 -
Neuroendocrine Response to Oral Alcohol Administration
|
Phase 1 | |
Recruiting |
NCT05343039 -
Technology Enhanced Adolescent Mental Health (TEAM)
|
N/A | |
Active, not recruiting |
NCT04070521 -
EEG Monitoring in the Emergency Department
|
||
Completed |
NCT03169244 -
Buproprion for Binge Drinking
|
Phase 2 | |
Recruiting |
NCT05246202 -
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
|
N/A | |
Completed |
NCT05036499 -
PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain
|
N/A | |
Recruiting |
NCT04368416 -
Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
|
||
Not yet recruiting |
NCT04557631 -
Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
|
||
Terminated |
NCT00890149 -
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
|
Phase 2 | |
Completed |
NCT02681406 -
Smartphone Based Continuing Care for Alcohol
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02448134 -
A Community-Based Strategy for Preventing Underage Drinking
|
N/A | |
Withdrawn |
NCT01796158 -
Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use
|
N/A | |
Withdrawn |
NCT01847300 -
cSBI-M for Young Military Personnel
|
N/A | |
Withdrawn |
NCT01511679 -
Brain-imaging and Adolescent Neuroscience Consortium
|
N/A | |
Completed |
NCT01553136 -
Varenicline Treatment of Alcohol Dependence in Smokers
|
Phase 2 | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Withdrawn |
NCT01275391 -
cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT00907309 -
Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use
|
Phase 1/Phase 2 |